Brief: Theravance Biopharma, Inc. Announces Appointment Of Jim Kelly, Managing Director At Weiss Asset Management, To Board Of Directors
11/04/2023 21:09
April 11 (Reuters) - Theravance Biopharma Inc TBPH.O :
* THERAVANCE BIOPHARMA, INC. ANNOUNCES APPOINTMENT OF JIM
KELLY,
MANAGING DIRECTOR AT WEISS ASSET MANAGEMENT, TO BOARD OF
DIRECTORS
* THERAVANCE BIOPHARMA INC - WITH APPOINTMENT OF KELLY, FOUR
NEW
DIRECTORS HAVE JOINED COMPANY'S BOARD OF DIRECTORS SINCE 2018
Source text for Eikon: ID:nPn4bjY64a
Further company coverage: TBPH.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Theravance Biopharma
See all newsIreland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth
Ireland's Theravance Biopharma Q4 revenue misses expectations
Corrected: BRIEF-Theravance Biopharma Q4 Operating Income USD 20.012 Million
U.S. STOCKS ON THE MOVE-Versant Media Group, Lithium miners, Expedia Group
U.S. STOCKS ON THE MOVE-Expedia Group, Blue Owl Capital, Enphase Energy